← Back to Search

Electronic Sepsis Alerts for Improved Inpatient Care (SEPTIC-IP Trial)

N/A
Waitlist Available
Led By Jason S Adelman, MD, MS
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age > 18 years-old
does not have an active order for "comfort measures only"
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days
Awards & highlights

SEPTIC-IP Trial Summary

This trial studies alerts for sepsis treatment in inpatient settings to see if nurses, prescribing clinicians, or both can improve treatment times.

Who is the study for?
This trial is for adults over 18 who are inpatients not in units for pregnant or peri-partum patients, without recent positive SARS-COV-2 tests, not on comfort-only care orders, and meet criteria for systemic inflammatory response syndrome (SIRS), but aren't already receiving sepsis treatment or enrolled in the SEPTIC study.Check my eligibility
What is being tested?
The trial examines if electronic alerts to nurses and/or prescribing clinicians about SIRS can speed up sepsis treatment. Patients will be randomly placed into one of four groups: no alerts, nurse-only alerts, clinician-only alerts, or both receiving alerts.See study design
What are the potential side effects?
Since this trial involves monitoring systems rather than medications or procedures, there are no direct side effects from interventions. However, the impact of alert fatigue on healthcare providers could indirectly affect patient care.

SEPTIC-IP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I am not under care focused solely on comfort.
Select...
I am currently staying in the hospital.

SEPTIC-IP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients treated with Surviving Sepsis Campaign (SSC) hour-1 bundle
Secondary outcome measures
Adverse antibiotic events
Median number of days of hospitalization
Number of positive blood cultures
+14 more

SEPTIC-IP Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Prescribing clinician alertExperimental Treatment1 Intervention
Participants will receive physician alert.
Group II: Nurse alert and prescribing clinician alertExperimental Treatment2 Interventions
Participants will receive physician alert and RN alert.
Group III: Nurse alertExperimental Treatment1 Intervention
Participants will receive RN alert.
Group IV: No alertActive Control1 Intervention
Participants will receive no physician alert or registered nurse (RN) alert.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,440,609 Total Patients Enrolled
Jason S Adelman, MD, MSPrincipal InvestigatorColumbia University
4 Previous Clinical Trials
34,905 Total Patients Enrolled
Benjamin L Ranard, MD, MSHPStudy DirectorColumbia University
1 Previous Clinical Trials
14,800 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research experiment currently open to participants?

"As indicated by clinicaltrials.gov, the recruitment process for this trial has been completed and is no longer seeking participants. This particular study was first posted on November 1st 2023 and last updated on October 31st 2023; however, 204 other trials are actively enrolling patients at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients
Jason Adelman 2023. "Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06117618.
All > Sepsis
~4800 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top